Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1992-8-19
|
| pubmed:abstractText |
The effects of buspirone and verapamil on spasmodic torticollis were investigated in two double-blind, placebo-controlled crossover studies. Buspirone was given in doses of 20-100 mg/day for 4 weeks to 14 patients; verapamil was given in doses of 40-100 mg/day for 3 weeks to 8 patients. Neither drug improved symptoms of the movement disorder (posture, motility, rigidity, tremor), pain, perceived stress, or mood, either in the whole group or in any individual patient.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0895-0172
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
82-4
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1627968-Adult,
pubmed-meshheading:1627968-Buspirone,
pubmed-meshheading:1627968-Dose-Response Relationship, Drug,
pubmed-meshheading:1627968-Double-Blind Method,
pubmed-meshheading:1627968-Drug Administration Schedule,
pubmed-meshheading:1627968-Female,
pubmed-meshheading:1627968-Humans,
pubmed-meshheading:1627968-Male,
pubmed-meshheading:1627968-Middle Aged,
pubmed-meshheading:1627968-Neurologic Examination,
pubmed-meshheading:1627968-Torticollis,
pubmed-meshheading:1627968-Verapamil
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Failure of buspirone and verapamil to improve spasmodic torticollis.
|
| pubmed:affiliation |
Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|